Edition:
United Kingdom

Advanced Medical Equipment & Technology

Page 1

CHF Solutions files for offering of up to $8.0 mln of common stock

Wednesday, 18 Oct 2017

Oct 18 (Reuters) - CHF Solutions Inc :CHF Solutions Inc files for offering of up to $8.0 million of common stock - SEC filing‍​.

SuperSonic Imagine reports sales growth of +13% in Q3

Wednesday, 18 Oct 2017

Oct 18 (Reuters) - SUPERSONIC IMAGINE SA ::SUPERSONIC IMAGINE REPORTS SALES GROWTH OF +13% IN Q3 2017 (+16% AT CONSTANT CURRENCY).Q3 REVENUE EUR ‍​6.4 MILLION VERSUS EUR 5.7 MILLION YEAR AGO.‍3(RD) QUARTER OF 2017, COMPANY GENERATED GROWTH OF +13% TO EUR 6.45 MILLION​.‍OVER FIRST NINE MONTHS OF 2017 SUPERSONIC IMAGINE RECORDED TOTAL REVENUES OF EUR 16.74 MILLION, UP 7%​.

Viveve releases preliminary Q3 2017 financial results

Wednesday, 18 Oct 2017

Oct 18 (Reuters) - Viveve Medical Inc :Viveve releases preliminary third quarter 2017 financial results.Viveve Medical- sees Q3 revenue from sale of 60 Viveve systems, about 2,700 disposable treatment tips, ancillary consumables to be about $4.1 million​‍​.

Mauna Kea Technologies appoints Olivier Regnard as CFO

Tuesday, 17 Oct 2017

Oct 17 (Reuters) - MAUNA KEA TECHNOLOGIES SAS ::MAUNA KEA TECHNOLOGIES APPOINTS OLIVIER REGNARD AS DEPUTY CEO AND CHIEF FINANCIAL OFFICER.

Viveve gets regulatory nod to market Viveve System in Mexico

Tuesday, 17 Oct 2017

Oct 17 (Reuters) - Viveve Medical Inc :Viveve announces regulatory approval for Viveve System in Mexico.Viveve Medical - received approval from Mexican regulatory authority, COFEPRIS, to market Viveve System in Mexico for treatment of vaginal introitus​.Viveve Medical Inc - working to submit IDE to FDA to conduct pivotal study on use of Viveve System for improvement in sexual function in women​.

Theraclion raises 4.2 million euros through private placement

Tuesday, 17 Oct 2017

Oct 17 (Reuters) - THERACLION SA ::RAISES EUR 4.2 MILLION THROUGH PRIVATE PLACEMENT WITH INSTITUTIONAL INVESTORS‍​.ISSUES 989,113 ORDINARY SHARES WITH CANCELLATION OF PREFERENTIAL SUBSCRIPTION RIGHTS FOR INSTITUTIONAL INVESTORS.ISSUES ORDINARY SHARES TO FUND PENDING CLINICAL TRIALS.PRICE OF PRIVATE PLACEMENT WAS SET AT EUR 4.22 PER SHARE.SETTLEMENT-DELIVERY TO TAKE PLACE ON OCT 19, 2017.

Restoration Robotics closes its initial public offering

Monday, 16 Oct 2017

Oct 16 (Reuters) - Restoration Robotics Inc :Restoration Robotics Inc. Announces closing of its initial public offering.Says initial public offering of 4.11 million common shares priced at $7.00 per share.

Sartorius AG says ‍full-year 2017 guidance adjusted

Monday, 16 Oct 2017

Oct 16 (Reuters) - Sartorius Ag - :9 ‍months business performance of Bioprocess solutions division in 2017 temporary weaker than expected ​.‍Key figures on 9-month business development in 2017​.‍Full-year 2017 guidance adjusted​.‍Mid-term outlook and targets remain unchanged​.‍For first nine months of 2017, Sartorius group achieved revenue growth of 8.6% in constant currencies to about 1.04 billion euros​.‍For first nine months of 2017, Sartorius group achieved an underlying EBIDTA margin of 24.8% versus 9 month 2016 25.0%​.‍Sartorius group now expects that sales revenue in constant currencies will increase by approx. 9% for full-year of 2017​.‍Underlying EBIDTA margin in constant currencies now projected to reach approx. Prior-Year level of around 25.0% for FY 2017​.

TETRAPHASE PHARMACEUTICALS APPOINTS KAM UNNINAYAR AS CFO

Monday, 16 Oct 2017

Oct 16 (Reuters) - Tetraphase Pharmaceuticals Inc ::TETRAPHASE PHARMACEUTICALS APPOINTS KAM UNNINAYAR AS CHIEF FINANCIAL OFFICER.‍MOST RECENTLY, KAMALAM UNNINAYAR​ SPENT OVER 11 YEARS OVERSEEING FINANCE ORGANIZATIONS AT THERMO FISHER SCIENTIFIC.KAMALAM UNNINAYAR MOST RECENTLY SPENT OVER 11 YEARS OVERSEEING FINANCE ORGANIZATIONS AT THERMO FISHER SCIENTIFIC​.

Analogic Corp to re-affirm its fiscal 2018 outlook ‍​

Monday, 16 Oct 2017

Oct 16 (Reuters) - Analogic Corp :Plans to re-affirm its fiscal 2018 outlook ‍​.Q1 revenue is expected to be lower than Q4 of fiscal 2017 - SEC filing​.As a result of co's completed restructuring actions, overall profitability is expected to improve in FY 2018 despite expected lower y-o-y revenues​.Fy2018 earnings per share view $2.81 -- Thomson Reuters I/B/E/S.Fy2018 revenue view $453.7 million -- Thomson Reuters I/B/E/S.

Markets

  • Sectors
  • Europe
  • U.S.
  • Asia

Sector Summary